118 related articles for article (PubMed ID: 16790091)
1. Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth.
Lee OH; Fueyo J; Xu J; Yung WK; Lemoine MG; Lang FF; Bekele BN; Zhou X; Alonso MA; Aldape KD; Fuller GN; Gomez-Manzano C
Neoplasia; 2006 May; 8(5):419-28. PubMed ID: 16790091
[TBL] [Abstract][Full Text] [Related]
2. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.
Guo P; Imanishi Y; Cackowski FC; Jarzynka MJ; Tao HQ; Nishikawa R; Hirose T; Hu B; Cheng SY
Am J Pathol; 2005 Mar; 166(3):877-90. PubMed ID: 15743799
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of angiogenesis related factors in glioma.
Osada H; Tokunaga T; Hatanaka H; Kawakami T; Tsuchida T; Abe Y; Tsugu A; Kijima H; Yamazaki H; Shima K; Osamura Y; Ueyama Y; Nakamura M
Int J Oncol; 2001 Feb; 18(2):305-9. PubMed ID: 11172596
[TBL] [Abstract][Full Text] [Related]
5. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.
Cortes-Santiago N; Hossain MB; Gabrusiewicz K; Fan X; Gumin J; Marini FC; Alonso MM; Lang F; Yung WK; Fueyo J; Gomez-Manzano C
Oncotarget; 2016 Mar; 7(13):16146-57. PubMed ID: 26910374
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.
Hu B; Guo P; Fang Q; Tao HQ; Wang D; Nagane M; Huang HJ; Gunji Y; Nishikawa R; Alitalo K; Cavenee WK; Cheng SY
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8904-9. PubMed ID: 12861074
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors.
Udani V; Santarelli J; Yung Y; Cheshier S; Andrews A; Kasad Z; Tse V
Neurol Res; 2005 Dec; 27(8):801-6. PubMed ID: 16354539
[TBL] [Abstract][Full Text] [Related]
8. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
[TBL] [Abstract][Full Text] [Related]
10. MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor model.
Valable S; Eddi D; Constans JM; Guillamo JS; Bernaudin M; Roussel S; Petit E
Neuro Oncol; 2009 Oct; 11(5):488-502. PubMed ID: 19168695
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
[TBL] [Abstract][Full Text] [Related]
12. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.
Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M
Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
14. Blocking Angiopoietin-2 Promotes Vascular Damage and Growth Inhibition in Mouse Tumors Treated with Small Doses of Radiation.
Kallio P; Jokinen E; Högström J; Das S; Heino S; Lähde M; Brodkin J; Korhonen EA; Alitalo K
Cancer Res; 2020 Jun; 80(12):2639-2650. PubMed ID: 32312835
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiopoietin 2 attenuates lumen formation of tumour-associated vessels in vivo.
Suzuki R; Yamamoto H; Ngan CY; Ohtsuka M; Kitani K; Uemura M; Nishimura J; Takemasa I; Mizushima T; Sekimoto M; Minamoto T; Doki Y; Mori M
Int J Oncol; 2013 Nov; 43(5):1447-55. PubMed ID: 23982687
[TBL] [Abstract][Full Text] [Related]
16. BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2.
Wang F; Li C; Han F; Chen L; Zhu L
Aging (Albany NY); 2021 Nov; 13(22):24675-24685. PubMed ID: 34815366
[TBL] [Abstract][Full Text] [Related]
17. Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression.
Feng Y; vom Hagen F; Pfister F; Djokic S; Hoffmann S; Back W; Wagner P; Lin J; Deutsch U; Hammes HP
Thromb Haemost; 2007 Jan; 97(1):99-108. PubMed ID: 17200776
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
[TBL] [Abstract][Full Text] [Related]
19. In utero angiopoietin-2 gene delivery remodels placental blood vessel phenotype: a murine model for studying placental angiogenesis.
Geva E; Ginzinger DG; Moore DH; Ursell PC; Jaffe RB
Mol Hum Reprod; 2005 Apr; 11(4):253-60. PubMed ID: 15734895
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
